CACLP & CISCE 2021 was successfully held in Chongqing International Expo Center from Mar 28th to 30th. During three days, 80,000 m2 exhibition space received 38,346 visitors. The total number of exhibitors hit the record of 1,188, with 18% growth compared with 2020, which covered the whole industry from upstream to downstream worldwide. Alongside CACLP & CISCE 2021, a series of high-quality academic conferences and near a hundred of business workshops also achieved a great success, including the 8th China IVD Industry Development Conference, the 6th China Experimental Medicine Conference / Wiley Conference on In Vitro Diagnostics, Enlightening Lab Med--the 4th IVD Youth Entrepreneur Forum, the 3rd China IVD Distribution Enterprise Forum and the 1st China Key Raw Material & Parts Forum.
In 2021, the impact of COVID-19 continues to spread across the globe. In this severe situation, the success of CACLP & CISCE 2021 cannot be divorced from the support of relevant institutions and the eager expectation of IVD Industry colleagues.
In the opening ceremony, Mr. Xizhao DOU, Chairman of National Association of Health Industry and Enterprise Management gave a kind welcome to everyone. He said, in the past three decades, CACLP has always been committed to the development of in vitro diagnostic industry, and gradually become the driving force for the continuous progress of the industry.
PhD. Zhiming JIANG, Vice President of Beckman Coulter Diagnostics & General Manager of China commented CACLP & CISCE 2021 will further promote the vigorous development and progress of the whole industry chain of in vitro diagnostics together.
Evan SHA, General Manager of CACLP said since the beginning of 2020, CACLP has met severe period in domestic and abroad. However, CACLP reached another peak in the exhibition space and the number of exhibitors and visitors, which demonstrated CACLP is the leader of the global in vitro diagnostic industry.
Jor ZHOU, Chairman of CACLP, later announced the beginning of CACLP & CISCE 2021.
“In comparison with CACLP 2018, which is the first time in Chongqing, the exhibitors of CACLP increased 58% from 751 to 1,188 in 3 years. China IVD market has great potential for future development, and we do have the responsibility to care and support local production, R&D, and distribution companies with higher vision.” said Haibo SONG, Founder of CACLP, Associate Dean of Shanghai Academy of Experimental Medicine, Vice Chairman of National Association of Health Industry and Enterprises Management, Chairman of China Association of In Vitro Diagnostics in an interview.
The success of CACLP & CISCE 2021 and its concurrent conferences have encouraged the whole industry during the special post-epidemic period to go further. We look forward to seeing you again in next March!
